Healthcare provider profile · identity verified

Azra Wiqas, MD

Internal Medicine · QUEENS VILLAGE, NY · NPI 1033210646

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	879	213
Amlodipine Besylate	Amlodipine Besylate	774	194
Metformin Hcl	Metformin Hcl	686	158
Losartan Potassium	Losartan Potassium	467	127
Levothyroxine Sodium	Levothyroxine Sodium	397	86
Rosuvastatin Calcium	Rosuvastatin Calcium	352	104
Omeprazole	Omeprazole	289	70
Metoprolol Succinate	Metoprolol Succinate	281	72
Hydrochlorothiazide	Hydrochlorothiazide	249	64
Pantoprazole Sodium	Pantoprazole Sodium	222	54
Fluticasone Propionate	Fluticasone Propionate	199	81
Simvastatin	Simvastatin	193	44
Tradjenta	Linagliptin	193	32
Famotidine	Famotidine	190	61
Tamsulosin Hcl	Tamsulosin Hcl	186	43
Jardiance	Empagliflozin	180	37
Trulicity	Dulaglutide	163	24
Albuterol Sulfate Hfa	Albuterol Sulfate	157	55
Lisinopril	Lisinopril	151	41
Gabapentin	Gabapentin	130	43
Carvedilol	Carvedilol	123	33
Glimepiride	Glimepiride	123	31
Montelukast Sodium	Montelukast Sodium	120	30
Januvia	Sitagliptin Phosphate	116	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	110	30
Metoprolol Tartrate	Metoprolol Tartrate	107	30
Clopidogrel	Clopidogrel Bisulfate	102	36
Alendronate Sodium	Alendronate Sodium	93	35
Chlorthalidone	Chlorthalidone	88	22
Pure Comfort Alcohol Pad	Alcohol Antiseptic Pads	86	16
Fenofibrate	Fenofibrate Nanocrystallized	82	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	21
Alcohol Prep Pads	Alcohol Antiseptic Pads	79	32
Eliquis	Apixaban	77	18
Atenolol	Atenolol	76	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	76	15
Ammonium Lactate	Ammonium Lactate	71	28
Lactulose	Lactulose	71	14
Diclofenac Sodium	Diclofenac Sodium	68	35
Furosemide	Furosemide	64	26
Pioglitazone Hcl	Pioglitazone Hcl	59	12
Potassium Chloride	Potassium Chloride	59	12
Enalapril Maleate	Enalapril Maleate	55	12
Ozempic	Semaglutide	51	14
Trazodone Hcl	Trazodone Hcl	51	17
Ramipril	Ramipril	50	13
Triamcinolone Acetonide	Triamcinolone Acetonide	50	29
Donepezil Hcl	Donepezil Hcl	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	14
Ezetimibe	Ezetimibe	47	11
Novolog Flexpen	Insulin Aspart	45	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	24
Vitamin D2	Ergocalciferol (Vitamin D2)	44	14
Prednisone	Prednisone	41	25
Finasteride	Finasteride	40	11
Ketoconazole	Ketoconazole	39	13
Farxiga	Dapagliflozin Propanediol	36	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	34	13
Glipizide	Glipizide	33	suppressed
Glipizide Er	Glipizide	33	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	18
Meloxicam	Meloxicam	32	21
Nifedipine Er	Nifedipine	32	11
Vascepa	Icosapent Ethyl	32	suppressed
Alprazolam	Alprazolam	31	11
Felodipine Er	Felodipine	31	suppressed
Valsartan	Valsartan	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	12
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Ranolazine Er	Ranolazine	26	suppressed
Clonazepam	Clonazepam	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Repaglinide	Repaglinide	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	20	suppressed
Hydrocortisone	Hydrocortisone	19	12
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	19	suppressed
Calcitriol	Calcitriol	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Single Use Swab	Alcohol Antiseptic Pads	18	11
Amoxicillin	Amoxicillin	17	suppressed
Azithromycin	Azithromycin	17	17
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Nystatin	Nystatin	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Glipizide Xl	Glipizide	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Halobetasol Propionate	Halobetasol Propionate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error